CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 200 enrolled
Drug / intervention
naproxen sodium+codeine phosphate, naproxen sodium+dexamethasone, naproxen sodium, paracetamoldrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04066426
NCT04066426Phase 4Completed

Analgesic Efficacy of Naproxen-codeine, Naproxen+Dexamethasone, and Naproxen on Myofascial Pain: A Randomized Double-blind Controlled Trial

Yuzuncu Yil University·interventional·Posted Aug 26, 2019·Updated Feb 15, 2021

In Brief

A Phase 4 clinical trial evaluating naproxen sodium+codeine phosphate, naproxen sodium+dexamethasone, naproxen sodium, paracetamol for Temporomandibular Disorder. Completed, enrolled 200 participants across 1 site.

Detailed Summary

Temporomandibular disorders (TMDs) are one of the most common muco-skeletal disorders, seen in the dental clinics. Many factors work together to initiate or aggravate the condition, so it is a multifactorial disorder. The etiology of TMDs may be a result of parafunctional habits such as clenching and bruxism, acute trauma to the jaw, trauma from hyperextension e.g. after a long dental treatment, joint laxity, psychological distress, occlusal disharmony like presence of high crown or free-end saddle leading to joint instability or systemic diseases such as Rheumatoid arthritis or Osteoarthritis. The aim of this study was to evaluate the effects of naproxen sodium+codeine phosphate, naproxen sodium+dexamethasone, and naproxen sodium on pain in patients complaining from temporomandibular pain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesTurkey (Türkiye)
Collaborators--

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedAug 26, 2019
Enrollment StartMar 1, 2018
Primary CompletionApr 1, 2019
Study CompletionJul 15, 2019
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 6.9 years ago

Interventions

naproxen sodium+codeine phosphate, naproxen sodium+dexamethasone, naproxen sodium, paracetamoldrug

NSAID, steroid, opioid, paracetamol and combinations of this drugs can be used in temporomandibular disorders.